What You Should Know:
- AppliedVR, a leader in immersive therapeutic solutions, has announced the launch of their flagship product, RelieVRx®, into the workers' compensation market. This FDA-authorized virtual reality (VR) program is the first of its kind to offer comprehensive, non-pharmacological treatment for chronic lower back pain (CLBP
- AppliedVR's RelieVRx® program signifies a significant advancement in pain management for workers' compensation claims.
A
Read More
AppliedVR
VA Expands Access to Virtual Reality Pain Therapy for Veterans with AppliedVR Partnership
What You Should Know:
- The U.S. Department of Veterans Affairs (VA) is taking a major step forward in pain management by expanding its contract with AppliedVR, a provider of immersive therapeutics (ITx) using virtual reality (VR).
- This contract expansion will significantly increase access to RelieVRx®, the first and only FDA-authorized in-home VR treatment for chronic lower back pain (CLBP).\
Continue Use of Virtual Reality for Treating Chronic Low Back Pain
Chronic pain affects
Read More
AppliedVR Releases Clinical Trial Results from In-Home Virtual Reality Program for Chronic Lower Back Pain
What You Should Know:
- AppliedVR, an immersive therapeutics pioneer, conducted a large randomized controlled trial (RCT) on virtual reality (VR) therapy for treating chronic low back pain (CLBP) at home.
- Results of the study were published in Mayo Clinic Proceedings: Digital Health and demonstrated that AppliedVR's RelieVRx program produced clinically meaningful improvements in adults with CLBP.
- AppliedVR aims to provide a non-pharmacological and non-invasive approach to treating
Read More
AppliedVR Becomes First Virtual Reality Provider to Receive HCPCS Level II Code
What You Should Know:
-AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel approach to medicine, today announced that the Centers for Medicare and Medicaid Services (CMS) established a unique Healthcare Common Procedure Coding System (HCPCS) Level II code (E1905) for its flagship product, the RelieVRx program.
- Defined as a virtual reality (VR) cognitive behavioral therapy (CBT) device that includes pre-programmed therapy software, CMS’ coding decision categorizes the
Read More
VA Provides Veterans with Immersive, VR Treatment for Chronic Lower Back Pain
What You Should Know:
- AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel, virtual reality-based approach to medicine, today announced a contract with the U.S. Department of Veterans Affairs (VA) to provide its FDA-authorized RelieVRx (formerly EaseVRx) solution to select Veterans impacted by chronic lower back pain (CLBP).
- AppliedVR was awarded the contract with the VHA Innovation Ecosystem, a division of the VA that discovers, evaluates, and
Read More
Techstars Relaunches Healthcare Accelerator in Los Angeles
What You Should Know:
- Techstars, a global investment business that provides access to capital, one-on-one mentorship, and customized programming for early-stage entrepreneurs announces today the relaunch of Techstars Healthcare sponsored by Cedars-Sinai, Point32Health, UCI Health, and UnitedHealthcare.
- The consortium-led accelerator program will be based in Los Angeles and select 12 high-growth startups to participate in its intensive 13-week program. Startups will receive capital,
Read More
Komodo Health & AppliedVR Partner to Drive Therapeutic VR for Chronic Pain
What You Should Know:
- Komodo Health, a company delivering patient-level insights by dynamically analyzing the broadest array of data across patients, practitioners, and health systems. today announced a new partnership with AppliedVR, the leader in therapeutic virtual reality (VR) for pain management.
- Using Komodo’s technology, AppliedVR will combine its proprietary insights with Komodo’s real-world data to conduct clinical research into the efficacy, cost savings, and health system
Read More
AppliedVR Awarded FDA Approval for VR Therapeutic for Lower Back Pain
What You Should Know:
- AppliedVR, an L.A.-based advancing the next generation of immersive therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted de novo approval for its flagship immersive therapeutic, EaseVRx, to treat chronic low back pain, which previously received breakthrough device designation in 2020. The news also comes on the heels of AppliedVR announcing its $36M series B funding round, bringing its total funding to $71M.
- Following
Read More
AppliedVR Secures $36M to Scale Therapeutic Virtual Reality Platform for Pain Management
What You Should Know:
- AppliedVR, a Los Angeles, CA-based company advancing the next generation of immersive therapeutics, today announced $36 million in series B funding, bringing its total funding to $71M. The round, which included investments from F-Prime Capital, JAZZ Venture Partners, Sway Ventures and SVB Ventures, set up AppliedVR for rapid growth as it prepares for its decision from the FDA on its first de novo submission.
- Virtual reality provides an immersive experience that
Read More
Curebase, AppliedVR Partner on Multiple VR Therapy Clinical Trials
What You Should Know:
- Curebase, a company committed to democratizing access to clinical studies, and AppliedVR, a pioneer advancing the next generation of digital medicine, today announced a one-year partnership where AppliedVR will deploy the Curebase platform to run five clinical trials assessing the effectiveness of virtual reality-based (VR) therapy to treat chronic pain.
- AppliedVR is the most evidence-based therapeutic VR platform for pain management and has been used by
Read More
